
### [MONDO:0019737](http://purl.obolibrary.org/obo/MONDO_0019737)
**Label:** thrombotic microangiopathy

**Subclasses:** [MONDO:0012350](http://purl.obolibrary.org/obo/MONDO_0012350) (complement factor H deficiency), [MONDO:0014005](http://purl.obolibrary.org/obo/MONDO_0014005) (immunoglobulin-mediated membranoproliferative glomerulonephritis), [MONDO:0018896](http://purl.obolibrary.org/obo/MONDO_0018896) (thrombotic thrombocytopenic purpura), [MONDO:0016244](http://purl.obolibrary.org/obo/MONDO_0016244) (atypical hemolytic-uremic syndrome), [MONDO:0009335](http://purl.obolibrary.org/obo/MONDO_0009335) (hemolytic uremic syndrome, atypical, susceptibility to, 1), 

**Corr. equiv. classes:** [OMIM:609814](http://purl.obolibrary.org/obo/OMIM_609814), [Orphanet:329918](http://www.orpha.net/ORDO/Orphanet_329918), [Orphanet:329903](http://www.orpha.net/ORDO/Orphanet_329903), [Orphanet:357008](http://www.orpha.net/ORDO/Orphanet_357008), [Orphanet:90038](http://www.orpha.net/ORDO/Orphanet_90038), [Orphanet:2134](http://www.orpha.net/ORDO/Orphanet_2134), [OMIM:235400](http://purl.obolibrary.org/obo/OMIM_235400), [Orphanet:93579](http://www.orpha.net/ORDO/Orphanet_93579), [OMIM:615008](http://purl.obolibrary.org/obo/OMIM_615008), [OMIM:274150](http://purl.obolibrary.org/obo/OMIM_274150), [OMIM:612923](http://purl.obolibrary.org/obo/OMIM_612923), [Orphanet:93581](http://www.orpha.net/ORDO/Orphanet_93581), [OMIM:612922](http://purl.obolibrary.org/obo/OMIM_612922), [Orphanet:54370](http://www.orpha.net/ORDO/Orphanet_54370), [Orphanet:93571](http://www.orpha.net/ORDO/Orphanet_93571), [OMIM:612925](http://purl.obolibrary.org/obo/OMIM_612925), [Orphanet:54057](http://www.orpha.net/ORDO/Orphanet_54057), [OMIM:612924](http://purl.obolibrary.org/obo/OMIM_612924), [Orphanet:200421](http://www.orpha.net/ORDO/Orphanet_200421), [OMIM:612926](http://purl.obolibrary.org/obo/OMIM_612926), 

**Class expressions from DL-Learner:**

- [HP:0001937](http://purl.obolibrary.org/obo/HP_0001937) (Microangiopathic hemolytic anemia) 72.50%
- [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 70.00%
- [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) 70.00%
- [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 70.00%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 70.00%
- [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 70.00%
- [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) 70.00%
- [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 70.00%
- [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) and [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) 70.00%
- [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 70.00%
- [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) 70.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 70.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) 70.00%
- [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and [HP:0012100](http://purl.obolibrary.org/obo/HP_0012100) (Abnormal circulating creatinine level) 67.50%
- [HP:0004364](http://purl.obolibrary.org/obo/HP_0004364) (Abnormality of nitrogen compound homeostasis) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) 67.50%


